Regulacje i polityka gospodarcza · 02/10/2015

NIH to Grant Exclusive License to VuEssence for Acute Stroke Research

The National Institutes of Health is issuing a notice under 35 U.S.C. 209 and 37 CFR part 404, stating its intention to grant a start-up exclusive license to VuEssence, a Florida-based company, to practice inventions related to acute stroke, as described in the specified patents.